1. Home
  2. LEXX vs BWEN Comparison

LEXX vs BWEN Comparison

Compare LEXX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$3.19

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Logo Broadwind Inc.

BWEN

Broadwind Inc.

N/A

Current Price

$4.22

Market Cap

100.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LEXX
BWEN
Founded
2004
N/A
Country
Canada
United States
Employees
N/A
341
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
100.5M
IPO Year
2011
2009

Fundamental Metrics

Financial Performance
Metric
LEXX
BWEN
Price
$3.19
$4.22
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $6.83
AVG Volume (30 Days)
82.6K
★ 151.1K
Earning Date
07-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 360.00
EPS
N/A
★ N/A
Revenue
$705,923.00
★ $146,785,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6,915.00
$4.14
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 52.05
N/A
52 Week Low
$0.35
$1.88
52 Week High
$14.37
$5.70

Technical Indicators

Market Signals
Indicator
LEXX
BWEN
Relative Strength Index (RSI) 35.47 46.01
Support Level $0.57 $4.10
Resistance Level $12.89 $4.15
Average True Range (ATR) 0.51 0.17
MACD -0.12 0.01
Stochastic Oscillator 25.92 55.56

Price Performance

Historical Comparison
LEXX
BWEN

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.

Share on Social Networks: